{'fraction_non_alphanumeric': 0.010471204188481676, 'fraction_numerical': 0.006980802792321117, 'mean_word_length': 5.1063829787234045, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Time to move to a glycated haemoglobin‐based algorithm for diabetes screening and diagnosis?

Diabetes poses a considerable health threat in Australia and is predicted to soon become the largest contributor to the burden of disease in this country.1 There are an estimated 1 million Australians with diabetes, and another 2 million at high risk of developing the disease.2 Many people with diabetes remain undiagnosed and an important strategy for reducing the disease burden is to detect and treat it earlier in order to minimise the risk of its devastating complications.